An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Medpace Holdings (Nasdaq: MEDP) will present at Baird’s Global Healthcare Conference on September 14, 2021, at 8:30 a.m. ET. The presentation will feature Jesse Geiger, President, and Kevin Brady, CFO. A live webcast will be available on the company’s website with replay options following the event.
Medpace is a global clinical contract research organization providing comprehensive clinical development services across various therapeutic areas, employing around 4,100 people in 40 countries.
Positive
None.
Negative
None.
CINCINNATI--(BUSINESS WIRE)--
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference:
Baird’s Global Healthcare Conference
Date: Tuesday, September 14, 2021 Presentation: 8:30 a.m. ET Speakers: Jesse Geiger, President, and Kevin Brady, Chief Financial Officer
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event.
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries as of June 30, 2021.
